Exchange: NASDAQ·Updated 11:27 AM EST

ODT Odonate Therapeutics

$50,000.00
$126,040.00
(71.60%)
Today
Mkt Cap$54.85B
Vol1.00

About ODT

Odonate, Inc. is a pharmaceutical company, which engages in the development of therapeutics that improve and extend the lives of patients with cancer. It focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The company was founded in March 2013 and is headquartered in New York, NY.
75

Extremely Bullish Sentiment

How do you feel about ODT?

Advertisement|Remove ads.